Recently Viewed

News Announcement

Aurobindo Pharma: Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.

26-Mar-2021 Follow Value Research Online on Google download pdfDownload PDF Aurobindo Pharma

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on March 26 2021 for RPR Sons Advisors Pvt Ltd P Suneela Rani (Jointly holding)

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.